Egyszerű nézet

dc.contributor.author Ponyi, Andrea
dc.contributor.author Borgulya G,
dc.contributor.author Constantin, Tamás
dc.contributor.author Váncsa, Andrea
dc.contributor.author Gergely, Lajos
dc.contributor.author Dankó, Katalin
dc.date.accessioned 2018-06-20T13:10:58Z
dc.date.available 2018-06-20T13:10:58Z
dc.date.issued 2005
dc.identifier 12344327640
dc.identifier.citation pagination=83-88; journalVolume=44; journalIssueNumber=1; journalTitle=RHEUMATOLOGY (UNITED KINGDOM);
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/4260
dc.identifier.uri doi:10.1093/rheumatology/keh404
dc.description.abstract OBJECTIVES: To present the outcome of patients with idiopathic inflammatory myositis, focusing on functional ability and quality of life. METHODS: Analysis was performed using data from 105 adult patients with definitive polymyositis, dermatomyositis or overlap myositis, who were followed up at a single centre. The diagnosis was made between 1979 and 2000 based on Bohan and Peter's criteria. Functional ability was assessed after a minimum follow-up of 3 yr with the Health Assessment Questionnaire Disability Index (HAQDI) and quality of life was measured with the Short Form 36-item questionnaire (SF-36). RESULTS: Fifteen patients in our cohort died and 87 participated in the evaluation of functional outcome. Functional ability after a median follow-up of 107.1 months (range 36.4-273.3) was heterogeneous. The median HAQDI score was 0.875 (range 0-2.875). Polyphasic or chronic-progressive disease course, osteoporosis and long-term follow-up were predictive of higher HAQDI scores. In terms of quality of life, significant differences from population norms were shown in all domains of the SF-36. There were no significant differences in the SF-36 scores among the patients according to clinicopathological subset or disease course. CONCLUSIONS: Although the mortality of our cohort was favourable, myositis continues to have a great impact on life in the medium and long term. The present work indicates that myositis patients have a significantly poorer quality of life than the normal population, but there was no difference among the patients according to clinicopathological subsets.
dc.relation.ispartof urn:issn:1462-0324
dc.title Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis
dc.type Journal Article
dc.date.updated 2017-04-05T08:51:48Z
dc.language.rfc3066 en
dc.identifier.mtmt 1633279
dc.identifier.wos 000226187300015
dc.identifier.pubmed 15381789
dc.contributor.department SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet